Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Levoin

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry|January 10, 2021
Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinaseDabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Structure Activity Relationship Studies around <i>DB18</i>, a Potent and Selective Inhibitor of CLK KinasesDabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Organic & Biomolecular Chemistry|October 1, 2021
Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analoguesHippolyte Paysant, Siham Hedir, Frédéric Justaud, et al.
Nature Chemical Biology|November 16, 2018
Disrupting the CD95-PLCγ1 interaction prevents Th17-driven inflammationAmanda Poissonnier, Jean-Philippe Guégan, Ha Thanh Nguyen, et al.
Immunity|July 21, 2016
CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone MiceAmanda Poissonnier, Doriane Sanséau, Matthieu Le Gallo, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry|January 10, 2021
Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinaseDabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Structure Activity Relationship Studies around <i>DB18</i>, a Potent and Selective Inhibitor of CLK KinasesDabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Organic & Biomolecular Chemistry|October 1, 2021
Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analoguesHippolyte Paysant, Siham Hedir, Frédéric Justaud, et al.
Nature Chemical Biology|November 16, 2018
Disrupting the CD95-PLCγ1 interaction prevents Th17-driven inflammationAmanda Poissonnier, Jean-Philippe Guégan, Ha Thanh Nguyen, et al.
Immunity|July 21, 2016
CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone MiceAmanda Poissonnier, Doriane Sanséau, Matthieu Le Gallo, et al.
Pageof 4